San Diego, CA, United States of America

Boris I Ratnikov

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Boris I. Ratnikov in Platelet Binding Assays

Introduction: Boris I. Ratnikov, based in San Diego, California, is an influential inventor known for his significant contributions to the field of medical diagnostics. With a focus on improving the methodologies used for assessing platelet binding functions in blood samples, Ratnikov has demonstrated a commitment to advancing medical technology.

Latest Patents: Among his notable achievements, Ratnikov holds a patent for "Agglutinimetric platelet binding assays in blood." This innovative methodology addresses the challenges associated with interference from whole blood during the determination of platelet binding function. By utilizing small particles bound with fibrinogen that contain an infrared light absorbing dye, his method facilitates the accurate measurement of platelet binding in whole blood samples. The agglutination of platelets with these coated particles is detected by changes in infrared light absorption characteristics, marking a significant advancement in diagnostic procedures.

Career Highlights: Boris I. Ratnikov's career has been marked by a dedication to research and innovation. He works with Accumetrics, Inc., where his expertise contributes to the development of cutting-edge medical diagnostic tools. His work has not only enhanced the understanding of platelet functionality but has also provided a basis for improved patient diagnostics.

Collaborations: Throughout his career, Ratnikov has collaborated with esteemed colleagues, including Dennis A. Durbin and Theodore T. Lee. These collaborations reflect a synergy within the field, as they work together to push the boundaries of medical technology.

Conclusion: Boris I. Ratnikov's contributions to the field of hematology through his innovative patent for platelet binding assays are a testament to his expertise and dedication. As he continues to work within Accumetrics, Inc., his ongoing research promises to yield further advancements in the medical diagnostics arena, enhancing patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…